Articles
June 2, 2020
Announcing the 2019-2020 Advocacy for Impact Grant Recipients
The Alnylam 2019-2020 Advocacy for Impact grant recipients come from five countries across three continents, and will receive grants totaling USD $270,000.00...
Read More ›
June 1, 2020
We Stand Against All Forms of Racism and Discrimination
On June 1, 2020, we issued the following public statement in response to events unfolding in the United States as a result of the killing of George Floyd...
Read More ›
May 12, 2020
Alnylam Named a Great Place to Work in the UK and Switzerland for Second Year in a Row
Alnylam has been recognized for the second year in a row as a Best Workplace 2020 in the UK and in Switzerland.
Read More ›
May 6, 2020
Navigating the Winding Road to Drug Approvals
Learn about the winding road and key members involved in getting a new drug approved.
Read More ›
March 30, 2020
Alnylam's Response to COVID-19
Learn more about Alnylam's response to the COVID-19 pandemic.
Read More ›
March 6, 2020
IWD 2020: Alnylam Women Reflect on Personal Experiences & Inspiration
We asked Alnylam women from across the globe to share to share a personal experience or inspiration that has shaped how they view gender and science at work.
Read More ›
February 25, 2020
Advocacy for Impact Grants: Updates from the Field
Learn about how patient organizations who received 2018-2019 Alnylam Advocacy for Impact Grants have been putting those funds to work.
Read More ›
February 19, 2020
Making Strides in Gender Parity
Alnylam ranked #3 in gender parity and #1 in fair representation for Women of Color (WOC) in Executive and Board Leadership among the top 25 employers in MA.
Read More ›
January 9, 2020
Expressing the Puzzling Challenges of hATTR Amyloidosis Through Art
We recently spoke with Peggy and her life partner Dan, who is living with hATTR amyloidosis, about their submission, At the Coffee Shop.
Read More ›
December 12, 2019
Building Bridges to Support Patients’ Care
Supporting patients and their caregivers by facilitating access to innovative treatments is at the core of our Patient Access Philosophy.
Read More ›
